Pluri Inc. (PLUR)
NASDAQ·Healthcare·Biotechnology
$3.37
+0.00%
Mkt Cap $27.51M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | $638.00K | $198.00K | -68.97% | -$0.65 | -$0.71 | -9.23% | — | — |
| Q4 2025 Nov 12, 2025 | $638.00K | $316.00K | -50.47% | -$0.74 | -$0.65 | +12.16% | — | — |
| Q3 2025 Sep 17, 2025 | $638.00K | $398.00K | -37.62% | -$0.65 | -$2.62 | -303.08% | — | — |
| Q2 2025 May 13, 2025 | $400.00K | $427.00K | +6.75% | -$0.73 | -$0.94 | -28.77% | — | — |
| Q1 2025 Feb 11, 2025 | — | $185.00K | — | — | -$0.53 | — | — | — |
| Q4 2024 Nov 12, 2024 | $80.14M | $326.00K | -99.59% | — | -$1.08 | — | — | — |
| Q3 2024 Sep 18, 2024 | $14.45M | $96.00K | -99.34% | $0.16 | -$2.98 | -1962.50% | — | — |
| Q2 2024 May 9, 2024 | $11.50M | $71.00K | -99.38% | -$0.24 | -$1.01 | -320.83% | — | — |
| Q1 2024 Feb 12, 2024 | — | $105.00K | — | — | -$0.96 | — | — | — |
| Q4 2023 Nov 13, 2023 | — | $54.00K | — | — | -$0.96 | — | — | — |
| Q3 2023 Sep 12, 2023 | — | $111.00K | — | -$2.48 | -$1.20 | +51.61% | — | — |
| Q2 2023 May 9, 2023 | — | $87.00K | — | -$2.40 | -$1.52 | +36.67% | — | — |
| Q1 2023 Feb 13, 2023 | — | $2.00K | — | -$2.56 | -$1.92 | +25.00% | — | — |
| Q4 2022 Nov 10, 2022 | — | $87.00K | — | -$0.32 | -$1.52 | -375.00% | — | — |
| Q3 2022 Sep 21, 2022 | — | $234.00K | — | -$0.35 | -$2.24 | -540.00% | — | — |
| Q2 2022 May 9, 2022 | $266.50K | $234.00K | -12.20% | -$0.36 | -$0.31 | +13.89% | — | — |
| Q1 2022 Feb 7, 2022 | — | — | — | -$0.38 | -$0.34 | +10.53% | — | — |
| Q4 2021 Nov 8, 2021 | — | — | — | -$0.41 | -$0.36 | +12.20% | — | — |
| Q3 2021 Sep 13, 2021 | — | — | — | -$0.40 | -$0.46 | -15.00% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$0.33 | -$0.48 | -45.45% | — | — |